Guideway Care provides Care Guidance—care coordination services that fill in the gaps between healthcare visits—using tech-enabled, non-clinical staff, with a proprietary platform that extends nurse capacity.

Care Guidance solves issues for patients, increases adherence to instructions, increases satisfaction and improves outcomes.

Care Guidance identifies and resolves the personal issues hidden within social determinants of health that influence behavior. The ability of Care Guidance to address these non-clinical issues makes it a versatile tool for addressing two key types of patients—profitable patients with whom hospitals must build loyalty and adhesiveness, and negative margin patients with whom they must control costs by changing behavior. Guideway Care offers an effective, scalable solution that can help hospitals effectively engage these patients in order to increase patient loyalty and reduce costs.

Care Guidance services are designed to ensure that issues are proactively identified and each interaction moves a patient towards positive action. Care Guidance accomplishes this through:

1. Trained Care Guides – non-clinical persons hired, trained and managed by Guideway Care to provide effective, efficient peer-to-patient outreach.

2. Disease-Specific Protocols – a library of evidence-based protocols and structured workflows targeted to each condition to ensure that the factors influencing individual patient health and well-being are addressed and no one falls through the cracks.

3. Comprehensive Care Guidance Technology – a comprehensive technology platform that ensures Care Guides provide the right intervention at the right time, every time, and supports patients with reminders, prep instructions, education and more.

Guideway Care works with companies, hospitals, specialty practices and health plans to support patients from initial interest (lead generation and conversion) through their entire care journey (planning, pre-procedure and post-discharge). Guideway’s people and processes help achieve better outcomes, improve patient satisfaction and reduce the costs of providing outstanding care. At the core of the Guideway solution is a fusion of advanced software and trained care guides. Our team and technology fills action gaps in care, compliance, communication and lead generation conversion. We deliver the lowest total cost of performance for clinical teams, marketing teams, administration and operations by focusing on non-clinical aspects that impact patient accountability and action, and our smart technology solutions and proven protocols to ensure a superior total experience for patients, families and care providers. In addition to the ways our Care Guides use our conversion success software to help change patient behavior while meeting their needs for information, direction and guidance, Guideway is helping providers and plans meet the challenges of a variety of Alternative Payment Models (APMs), including the Bundled Payments for Care Improvement Advanced (BPCI+) Initiative and the Hospital Readmissions Reduction Program (HRRP).

Eon uses the most advanced form of AI to create layered Computational Linguistics (CL) data science models. CL understands text and the linguistic structure of English, similar to how the human brain reads. EPM eliminates the noise by extracting clinically relevant information from radiology reports, saves FTE time, and improves patient outcomes.

EPM is the first and only solution to identify incidental pulmonary nodules on Magnetic Resonance (MR), X-Ray, and Computed Tomography (CT) reports. This update allows facilities to capture approximately 25% more incidental pulmonary nodules.

Eon is a digital health that has created the industry's first Intelligent Care platform. Our advanced AI integrates with your EHR to identify incidental findings with 98% accuracy. From there, our technology risk-stratifies patients, creates clear care plans, and automates patient/provider outreach to increase adherence and outcomes.

The company now works with more than 900 hospitals, and has impacted 2 million patients.